The clinical trials process is essential to investigating new treatments for many health conditions. There are many clinical trials underway utilizing Isotretinoin as a potential remedy for Kidney Cancer, Brain And Central Nervous System Tumors, Adult Anaplastic Astrocytoma Recurrent Adult Brain Tumor and Protocol Specific Unspecified Adult Solid Tumor. There are currently 8 Isotretinoin clinical trials ongoing in the State of Tennessee. Of these 2 clinical trials are currently active in Knoxville, Tennessee.
Some of these are:
- Isotretinoin With or Without Monoclonal Antibody Interleukin-2 and Sargramostim Following Stem Cell Transplantation in Treating Patients With Neuroblastoma
- Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Previously Untreated High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor
After enrolling in a research study you may receive medical evaluation and treatment at no cost. You may be compensated if you are eligible for one of the Isotretinoin research studies.